Actionnariat et activité des initiés pour Achieve Life Sciences, Inc. (ACHV): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $7.42 |
| Capitalisation | $762M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $15.2M | $5.3M | $9.5M | $16.7M | $35.9M | $43.0M | $24.7M | $15.5M | $12.7M | $20.9M |
| Placements à Court Terme | $10.2M | 0 | $5.1M | 0 | 0 | 0 | 0 | 0 | $21.6M | $15.5M |
| Créances | $510000 | $9000 | $7000 | $8000 | 0 | $153000 | $105000 | $111000 | 0 | 0 |
| Stocks | 0 | $222000 | -$50000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $27.2M | $5.9M | $15.5M | $17.3M | $37.0M | $44.6M | $27.3M | $17.0M | $36.5M | $39.9M |
| Immobilisations Corporelles | $271000 | $59000 | $35000 | $386000 | $146000 | $64000 | $123000 | $79000 | $119000 | $64000 |
| Goodwill | $1034 | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M |
| Actifs Incorporels | $2755 | $2.5M | $2.3M | $2.1M | $1.9M | $1.6M | $1.4M | $1.2M | $974000 | $751000 |
| Actifs Totaux | $27.5M | $9.9M | $19.1M | $21.1M | $40.3M | $47.5M | $30.0M | $19.4M | $38.6M | $41.8M |
| Dettes Fournisseurs | $2.1M | $213000 | $144000 | $859000 | $332000 | $841000 | $1.7M | $618000 | $1.9M | $867000 |
| Dette à Court Terme | $829000 | 0 | 0 | 0 | 0 | 0 | $16.1M | $16.7M | 0 | $3.7M |
| Passifs Courants | $8.5M | $2.0M | $3.3M | $2.9M | $2.9M | $4.5M | $21.6M | $20.8M | $6.7M | $9.1M |
| Dette à Long Terme | 0 | 0 | $12000 | 0 | 0 | $14.9M | 0 | 0 | $9.8M | $11.2M |
| Passifs Totaux | $8.5M | $2.0M | $3.3M | $3.0M | $3.0M | $19.5M | $21.7M | $20.8M | $17.7M | $20.3M |
| Réserves | -$196.9M | -$12.7M | -$25.4M | -$45.7M | -$60.4M | -$93.6M | -$135.9M | -$165.8M | -$205.6M | -$260.2M |
| Capitaux Propres | $19.0M | $7.9M | $15.8M | $18.1M | $37.3M | $28.0M | $8.3M | -$1.4M | $20.9M | $21.5M |
| Dette Totale | $106000 | $27000 | $35000 | $362000 | $169000 | $15.0M | $16.2M | $16.7M | $10.0M | $15.0M |
| Dette Nette | -$25.6M | -$5.3M | -$14.6M | -$16.3M | -$35.7M | -$28.0M | -$8.5M | $1.2M | -$24.4M | -$21.4M |
| Fonds de Roulement | $18.7M | $3.9M | $12.3M | $14.5M | $34.0M | $40.0M | $5.7M | -$3.8M | $29.8M | $30.8M |
Santé financière
| Dette / Capitaux propres | -1.02 |
| Ratio de liquidité | 0.95 |
Rentabilité
| Rentabilité des capitaux propres | -892.07% |
| Rentabilité du capital investi | -21425.74% |
| Rentabilité des actifs | -59.88% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ALLO · ARCT · AVIR · CAPR · HUMA · IMRX · SGMT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACHV: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions